Studies examining the effects of activity-based interventions haven’t required post-exertional malaise as a core criterion ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

Early voting turnout for New York City’s mayoral election is already five times higher than the 2021 general election. Data ...

Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...

It's been a heck of a year in academia. This podcast miniseries, in partnership with WNYC's On The Media, examines the moral calculus universities face in dealings with the Trump administration.

Our sex experts weigh in on how to have mind-blowing sex with an older queer woman. Our culture tends to be youth-obsessed, ...

Nutcracker Therapeutics is driving down costs, accelerating speed of processing and improving scalability with an end-to-end, GMP-grade production process. Healthcare is on the cusp of a ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

A look at the shareholders of KPJ Healthcare Berhad can tell us which group is most powerful. The group holding the most number of shares in the company, around 42% to be precise, ...

Good morning, and welcome to the SELLAS Life Sciences R&D Day. As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the ...

INGREZZA net product sales for the third-quarter 2025 were $687 million, reflecting 10% sequential growth over the second quarter of 2025 and 12% growth year-over-year. Double-digit volume growth was ...